The Latest Analyst Ratings for Definitive Healthcare
Portfolio Pulse from Benzinga Insights
Definitive Healthcare (NASDAQ:DH) has received 2 bullish and 3 indifferent analyst ratings in the last quarter. The company's average 12-month price target is $13.0, unchanged from the previous average. The high price target is $15.00 and the low is $10.00.
July 24, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Definitive Healthcare has received mixed analyst ratings, with an average 12-month price target of $13.0.
The company has received both bullish and indifferent ratings, indicating a mixed outlook. The unchanged average price target suggests that the analysts' view on the company has remained stable.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100